Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Effects of the COVID-19 Pandemic on Park Use in U.S. Cities

View ORCID ProfileJonathan Jay, Felicia Heykoop, View ORCID ProfileLinda Hwang, View ORCID ProfileJorrit de Jong, View ORCID ProfileMichelle Kondo
doi: https://doi.org/10.1101/2021.04.23.21256007
Jonathan Jay
1Boston University School of Public Health, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jonathan Jay
  • For correspondence: jonjay@bu.edu
Felicia Heykoop
1Boston University School of Public Health, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Linda Hwang
2Trust for Public Land, San Francisco, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Linda Hwang
Jorrit de Jong
3Harvard Kennedy School of Government, Cambridge, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jorrit de Jong
Michelle Kondo
4United States Forest Service
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michelle Kondo
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Introduction The COVID-19 pandemic focused attention on city parks as important public resources. However, it is unknown how city park use in 2020 compared to prior years and whether COVID-19 may have exacerbated racial/ethnic inequities in access. Moreover, traditional methods of measuring park use present major drawbacks.

Methods We analyzed monthly mobility data derived from a large panel of smartphone devices, cross-referenced with a database of parks locations sourced from local agencies. We assessed park use trends in 44 of the 50 most populous U.S. cities from January 2018 to November 2020 using interrupted time series regressions. We also compared parks to other city amenities (e.g., gyms and libraries).

Results Based on a sample of 5,559 city parks, park visits declined by 14.6% (95% CI [9.2, 19.7], p < 0.001) from March through November 2020, compared to prior levels and trends. When we segmented the COVID-19 period by time of widespread closures (March-April) and partial-to-full reopenings (May-November), we estimated a larger reduction during closures (35.7% reduction, 95% CI [33.5, 37.8], p < 0.001) compared to the reduction during reopenings (8.0% reduction, 95% CI [1.9, 13.7], p = 0.001). Reductions for other amenities were more prolonged. In park service areas where a greater proportion of residents were White, reopening was associated with more visits, suggesting that racial privilege influenced access.

Conclusions Smartphone mobility data can address a data availability gap for monitoring park use. Park use only declined modestly in 2020. Opportunities exist to make access more racially equitable.

Significance statement Parks are public resources that promote health. Little is known about how parks have been used during the COVID-19 pandemic, when parks have become particularly important public spaces. This study introduces an approach to monitor park use over time, using location data from smartphones. This approach enabled the authors to evaluate trends in park use during the pandemic, including major gaps in visits to parks according to whether they mostly served White residents or residents of color. This big data approach offers advantages over traditional methods for monitoring park use and can help city officials to identify and address inequities in park access.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

JJ, FH, and JdJ were supported by the Bloomberg Harvard City Leadership Initiative, funded by a gift to Harvard University by Bloomberg Philanthropies.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Since the mobility data were anonymized and other data were publicly available, the Boston University Medical Center institutional review board deemed this study exempt from review as non-human participants research.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • jonjay{at}bu.edu

  • fheykoop{at}bu.edu

  • Linda.Hwang{at}tpl.org

  • jorrit_dejong{at}hks.harvard.edu

  • michelle.c.kondo{at}usda.gov

Data Availability

Trust for Public Land data are publicly available at https://www.tpl.org/parkserve/downloads. Raw SafeGraph data cannot be shared due to data use agreement, but replication code will be posted prior to publication.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Back to top
PreviousNext
Posted April 25, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Effects of the COVID-19 Pandemic on Park Use in U.S. Cities
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Effects of the COVID-19 Pandemic on Park Use in U.S. Cities
Jonathan Jay, Felicia Heykoop, Linda Hwang, Jorrit de Jong, Michelle Kondo
medRxiv 2021.04.23.21256007; doi: https://doi.org/10.1101/2021.04.23.21256007
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Effects of the COVID-19 Pandemic on Park Use in U.S. Cities
Jonathan Jay, Felicia Heykoop, Linda Hwang, Jorrit de Jong, Michelle Kondo
medRxiv 2021.04.23.21256007; doi: https://doi.org/10.1101/2021.04.23.21256007

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Public and Global Health
Subject Areas
All Articles
  • Addiction Medicine (227)
  • Allergy and Immunology (500)
  • Anesthesia (110)
  • Cardiovascular Medicine (1226)
  • Dentistry and Oral Medicine (205)
  • Dermatology (147)
  • Emergency Medicine (282)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (528)
  • Epidemiology (9999)
  • Forensic Medicine (5)
  • Gastroenterology (497)
  • Genetic and Genomic Medicine (2442)
  • Geriatric Medicine (236)
  • Health Economics (479)
  • Health Informatics (1634)
  • Health Policy (750)
  • Health Systems and Quality Improvement (633)
  • Hematology (247)
  • HIV/AIDS (530)
  • Infectious Diseases (except HIV/AIDS) (11855)
  • Intensive Care and Critical Care Medicine (625)
  • Medical Education (251)
  • Medical Ethics (74)
  • Nephrology (267)
  • Neurology (2272)
  • Nursing (139)
  • Nutrition (349)
  • Obstetrics and Gynecology (451)
  • Occupational and Environmental Health (532)
  • Oncology (1244)
  • Ophthalmology (375)
  • Orthopedics (133)
  • Otolaryngology (226)
  • Pain Medicine (154)
  • Palliative Medicine (50)
  • Pathology (324)
  • Pediatrics (729)
  • Pharmacology and Therapeutics (311)
  • Primary Care Research (281)
  • Psychiatry and Clinical Psychology (2280)
  • Public and Global Health (4823)
  • Radiology and Imaging (833)
  • Rehabilitation Medicine and Physical Therapy (488)
  • Respiratory Medicine (650)
  • Rheumatology (283)
  • Sexual and Reproductive Health (237)
  • Sports Medicine (224)
  • Surgery (266)
  • Toxicology (44)
  • Transplantation (124)
  • Urology (99)